ArticleArthroplasty (London, England)2025
SPECT/CT and triple-phase bone scan: A valuable diagnostic approach for identifying indications for secondary patellar resurfacing in patients with unexplained anterior knee pain post-TKA.
Article in Arthroplasty (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sagittal alignment changes predict patellar osteosclerosis after total knee arthroplasty without resurfacing.Journal of experimental orthopaedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveThe efficacy of secondary patellar resurfacing (SPR) in alleviating anterior knee pain (AKP) following total knee arthroplasty (TKA) remains uncertain. The purpose of this study was to assess the suitability of SPR using single photon emission computed tomography/computed tomography (SPECT/CT) in conjunction with triple-phase bone scan (TPBS).
methodsWe performed a retrospective analysis on a prospectively-enrolled cohort of patients suffering from AKP in the context of TKA. In this cohort, we identified a subset of 17 patients (involving 18 knees), who had unexplained AKP and were potential candidates for secondary patellar resurfacing (SPR). The candidates for SPR were designated the experimental group, and subjects receiving other forms of treatment were referred to as the Control group. The selection for these treatment options was based on the findings from SPECT/CT and triple-phase bone scan (TPBS). Data collection spanned from preoperative to postoperative follow-up periods and encompassed basic demographics, preoperative findings of SPECT/CT plus TPBS, and Knee Society Score (KSS).
resultsSPECT/CT and TPBS revealed focal radionuclide concentration in the patella in 12 patients (13 knees) and in other locations in 5 patients (5 knees) with unexplained AKP, complementing the findings from medical history and physical examinations. The Experimental group showed signs of patellar maltracking or early-stage patellofemoral osteoarthritis (OA) following TKA and received SPR treatment. Postoperatively, the objective knee indicators score was significantly higher than preoperative scores (88.46 ± 5.77 vs. 76.38 ± 7.64, P < 0.05). Similarly, the functional activities score was significantly improved postoperatively (74.31 ± 6.68 vs. 50.46 ± 9.01, P < 0.05). Patient satisfaction score was substantially elevated after SPR (33.38 ± 2.87 vs. 17.08 ± 5.69, P < 0.05). The control group mainly included patients who experienced loosening, periprosthetic joint infection (PJI), or instability. These patients received revision surgeries tailored to their individual pathologies and postoperative follow-ups showed favorable outcomes.
conclusionsSPECT/CT in combination with TPBS may serve as a valuable tool for assessing the suitability of SPR for the post-TKA management of unexplained AKP. Video Abstract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.